伏利康纳诱导的肝损伤:在回顾性队列中的发病率模式和风险因素
1Department of Clinical Pharmacy, Zhejiang Provincial Key Laboratory for Drug Clinical Research and Evaluation, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China.
伏利康纳诱导的肝损伤影响11.32%的患者,静脉注射和先前存在的疾病是关键风险因素. 这项研究提出了一个针对抗真菌疗法个性化风险评估的框架.
科学领域:
- 药理学 药理学是指药理学的学科.
- 肝病学 肝病学是一种肝病学.
- 流行病学 流行病学
背景情况:
- 沃里科纳是侵入性阿斯伯吉洛症的关键抗真菌药物.
- 肝毒性是一种已知的风险,但缺乏全面的流行病学数据.
- 现有研究受到不一致的标准和小样本大小的限制.
研究的目的:
- 描述伏利康纳引起的肝损伤 (VILI) 的流行病学.
- 确定VILI的可修改和不可修改的风险因素.
- 为个性化抗真菌疗法开发一个风险分层框架.
主要方法:
- 对7659名成年患者的分析,这些患者在2007年至2020年期间接受了沃里可纳治疗.
- 确定VILI发生率和损伤模式 (肝细胞,胆固醇,混合).
- 单变量和多变量后勤回归用于识别风险因素;ROC分析用于模型性能.
主要成果:
- VILI发生率为11.32%,肝细胞 (5.01%),胆固醇 (5.19%) 和混合 (1.11%) 模式.
- 可修改的危险因素:静脉注射 (OR=1.88).
- 非可修改的预测因素包括尿素升高,甘油三,CRP,先前存在的肝病,糖尿病和移植状态.
结论:
- 静脉注射沃里康纳和特定的并发症显著增加VILI风险.
- 为优化抗真菌疗法,提出了一个新的风险分层框架.
- 个性化风险效益分析可以改善患者的治疗结果和安全.
更多相关视频
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
相关概念视频
Hepatic Drug Excretion: Influencing Factors
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
